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A series of dioleoyl N-(monomethoxy polyethylcneglycol succinyl)phosphatidylethanolamine (PEG-PE) of different polymer chain length was used 
in this study. Both the activity of PEG-PE in prolonging the circulation time of liposomes and the relative steric barrier activity of amphipathic 
polymer, measured by a liposome agglutination assay. were found to be directly proportional to the chain length of PEG-PE (PEGWJO-PE > 
PEG2000-PE > PEG750-PE). However, PEG5000-PE caused a reduced target binding of immunoliposomes in mice due to its overly strong steric 
barrier activity. The best PEG-PE species upporting the target binding of immunoliposomes was PEG2000-PE, the activity of which was compati- 
blc to that of ganglioside GM,. However, GM, only showed a weak steric barrier activity, suggesting a different mechanism for this glycolipid. 
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1. INTRODUCTION 
A novel type of liposome with a reduced affinity to 
cells in the reticuloendothelial system (RES) and hence 
with a prolonged circulation time has been the focus of 
much recent research in liposome targeting. This in- 
terest has been fueled by the prospect that this novel 
liposome provides an efficient delivery system for 
various bioactive agents to the cells or tissues other than 
the RES. To construct such liposomes, a glycolipid such 
as ganglioside GM, (GMI), hydrogenated phosphati- 
dylinositol, or sulfatide is included in the lipid composi- 
tion [l-4]. More recently, studies carried out in our 
laboratory have shown that the inclusion of amphi- 
pathic polyethyleneglycol (PEG5000) in the lipid com- 
position also effectively reduces uptake by the RES and 
results in prolonged circulation time of liposomes [5,6]. 
Similar results have been reported by several other 
laboratories [7,8]. The precise mechanism of action of 
these additional amphiphiles remains obscure at pre- 
sent, but it has been postulated [5] that increased 
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hydrophilicity of the liposomes may lead to an enhanc- 
ed stability and a ieduciion of nonspecific uptake by the 
RES. In addition, the steric barrier [7] on the liposome 
surface provided by these amphiphiles may reduce the 
interaction with unidentified opsonin molecules [9], 
leading to a reduction of specific uptake of liposomes 
by the RES. In the present study, we have examined the 
importance of the steric barrier on the liposome sur- 
face, provided by an additional amphiphile, in prolong- 
ing the circulation time of liposomes, using a series of 
polyethyleneglycols, with different chain lengths, con- 
jugated to phosphatidylethanolamine (PEG-PE) and 
GM,. The effects of these amphiphiles on the target 
binding of immunoliposomes were also studied. 
2. MATERIALS AND METHODS 
Sources and grades of chol, GM,, PC, and streptavidin have been 
described previously [6]. Synthesis of PEG-PEs with different 
polymer chain lengths (PEG750-PE, PEGZOOO-PE, PEG5OWPE) 
[5], biotic-cap-PE (lo], DTPA-SA [II], and NGPE [I21 have been 
previously described. 
2. I. Lib-osomc ap~lulinatiott ussay 
Liposomes used in this study were prepared from PC and chol (I: I, 
mol/mol) additionally containing 2.5 mol% biotin-cap-PE and 
various amounts (2, 5 and 10070) of PEG-PE, using the extrusion 
method as dcscribcd below. The agglutination was initiated by mixing 
the liposomc suspension (60 rg phospholipid in 560 ~1 PBS, pH 7.5) 
with IO pg strcptovidin in a microcuvctte and increase in turbidity WIS 
monitored by optical density at 440 nm. 
2.2. Liposaatc j3rqraratiorr 
Normally, liposont:s composed of PC and chol (IU:5, mol/mol) 
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additionally containing 6.3 mol% of either PEG-PE or GM, were 
prepared by the extrusion method as described previously [6]. Briefly, 
the solvent free lipid mixture containing I mol% “‘In-labeled DTPA- 
SA as a lipid marker [I l] was hydrated with PBS (pH 7.5) overnight, 
and the liposome suspension was extruded several times through 
stacked 0.4 and 0.2 pm Nucleopore membranes. Liposome size was 
determined by dynamic laser light scattering using a Coulter N4SD in- 
strument (Hialeah, FL). For the target binding study of im- 
munoliposomes. monoclonal antibody 34A (34A) bearing liposomes 
composed of PC and chol (l:l, mol/mol) additionally containing 7.0 
mol% of various PEG-PEs or GM, were prepared by the detergent 
dialysis method as described previously [13]. Briefly, the lipid mixture 
containing 1 mol% “‘In-labeled DTPA-SA solubilized with oc- 
tylglucoside was mixed with 34A conjugated to NGPE, followed by 
the removal of detergent by dialysis. The resulting 34A-liposomes 
were extruded, and the unbound antibody was then removed by col- 
umn chromatography on BioGel AI.SM. The antibody-to-lipid 
weight ratio of 34A-liposomes was determined by the specific radioac- 
tivities of “‘In for lipids and “‘1 for the antibody. 
2.3. Biodistribrrtion studies 
“‘In-labeled liposomes (400 gg lipid) were injected i.v. into male 
Balb/c mice. At various time intervals, Vo injected dose of liposomes 
in blood and major organs was examined by “‘In radioactivity coun- 
ting. determined using a Beckman gamma-counter. % injected dose 
in blood was determined by assuming that the blood volume of mouse 
is 7.3% of the body weight. 
3. RESULTS AND DISCUSSION 
We first examined the steric barrier activities of these 
PEG-P& using a liposome agglutination assay. This 
assay takes advantage of the fact that the agglutination 
of liposomes containing biotin-cap PI?, mediated by 
streptavidin, requires a close apposition of the 
neighboring liposomes [14], and thus the decrease in 
turbidity compared to control liposomes directly 
reflects the degree of steric barrier produced on the 
liposome surface. Data were expressed as a relative tur- 
bidity ratio of the test liposomes to liposomes compos- 
ed of PC and chol at 12 min after the incubation. At this 
time, the turbidity increase showed a plateau and was 
plotted as a function of the amphiphile concentration 
(Fig. 1). In all PEG-PEs tested here, the relative turbidi- 
ty decreased with increasing concentration of the 
polymer. Also, the longer the chain length of PEG, the 
greater the decrease in the relative turbidity. At 10 
mol%, liposome agglutination was inhibited by 14070, 
55%. 100070 for PEG750-PE, PEG2000-PE, PEG5000- 
PE containing liposomes, respectively. Thus, steric bar- 
rier activity is directly correlated to the chain length of 
PEG. Also shown in Fig. 1 is the steric barrier activity 
of GMI. The inhibition of liposome agglutination was 
also concentration dependent; however, GM, provided 
only a relatively weak steric barrier which teas less than 
that of PEG2000-PE. 
To test whether the steric barrier activity of PEG-PE 
and GM, correlates with the activity in prolonging the 
circulation time of liposomes and with the interaction 
of liposomes with the RES, the biodistribution of i.v. 
injected liposomes containing PEG-PE or GM1 was ex- 
amined at different imes after injection, The liposomes 
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Fig. I. Effect of increasing concentrations of PEG-PEs and GM, on 
streptavidin-induced agglutination of liposomes containing biotin- 
cap-PE. Increase of turbidity (o.d. 440 nm) was measured 12 min 
after incubation for liposomes composed of PC and chol (l:l, 
mol/mol) additionally containing PEG750-PE (o), PEGZWO-PE ( A ), 
PEG5000-PE (o), and GM, (0). Liposome agglutination was nor- 
malized with respect o the control liposomes (PC-chol) and was plot- 
ted as a function of concentration of PEG-PE and GM,. 
used in this study had an average diameter ange from 
189 nm to 244 nm since it has been shown that the 
liposomes larger than 300 nm in diameter have an in- 
creased tendency to accumulate in the spleen (161 and 
Liu, D. et al., submitted), whereas the small liposomes, 
less than 80 nm in diameter, accumulate in the liver very 
efficiently (Liu, D. et al., in preparation). Data were ex- 
pressed as Vo injected dose in blood and the RES (liver 
and spleen) and were plotted as a function of time after 
injection (Fig. 2). At 3 h after injection, liposomes com- 
posed of PC and chol were almost completely cleared 
from the circulation and accumulated exclusively in the 
liver and spleen. Inclusion of PEG-PE or GM1 in the 
lipid composition resulted in slower clearance rate from 
the circulation to a varying degree, The estimated half- 
life for liposome blood clearance increased from 0.5 h 
to 0.7 h, 1.7 h, 6,2 h and 3.4 h by the inclusion of 
PEG750-PE, PEG2000-PE, PEG5000-PE and GM1 in 
the lipid composition, respectively. In these mouse ex- 
periments, an increase of PEG750-PE concentration up 
to 10 mol% in liposomes resulted in a linear increase of 
liposomes in the circulation and a concurrent decrease 
in the RES, whereas the activities of PEG2000-PE and 
PEG5000-PE showed plateau at a concentration of 5 
mol% (data not shown). These results clearly indicate 
that, among the various PEGaPEs tested in this study, 
the activity of PEG-PE in prolonging the circulation 
time of liposomes is directly proportional to the chain 
length of the PEG polymer which is in turn propor- 
tional to the relative ste~it barrier activity of the PEG- 
PE as assessed by the liposome agglutination assay (Fig. 
1). 
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Fig. 2. Effect of various PEG-PEs and GM1 on (a) blood clearance and (b) the RES (liver and spleen) uptake of i.v. injected “‘in-labeled liposomes. 
Bars represent SD. (n = 3). Lipid composition and the average diameter of liposomes were: (x) PUchol (10:5), 201 nm; (0) PC/chol/PEG750-PE 
(10:5:1), 244 nm; (a) PC/chol/PEG2000-PE (l&5:1), 189 nm; ( q ) PC/chol/PEG5000-PE (lO:S:l), 194 nm; and (0) PC/chol/GMI (1O:S:l). 193 
nm. 
PEG is a linear polymer which exhibits considerable GM1 prolongs the circulation time of liposomes olely 
conformational flexibility and hence provides a reduced by presenting a steric barrier on the liposome surface. 
steric barrier activity when compared to a rigid One of the important uses of liposomes pith prolong- 
polymer. However, it has been reported that the PEG ed circulation time is ligand directed liposomal 
polymers on the liposome surface appear to be in a par- targeting. Previous studies have shown that optimal 
tially extended conformation as studied by X-ray target binding of immunoliposomes i achieved only if 
analysis [151. In addition, the steric barrier provided by GM1 is included in the lipid composition to reduce up- 
the amphipathic PEG1900 was estimated to be 6 nm take of immunoliposomes by the RES [16]. Further- 
thick, compared to 2.5 nm for GM, (calculated values more, although the activity of PEGSOOO-PE in prolong- 
using the data from [IS]). In other words, GM1 is a ing the circulation time of liposomes is greater than that 
weak steric barrier compared with PEG1900 in agree- of GM,, the inclusion of PEGSOOO-PE in immunolipo- 
ment with our data from the liposome agglutination somes resulted in a lower level of target binding 
assay (Fig. 1). The results of this agglutination assay presumably due to its strong steric barrier activity 
and the biodistribution study of liposomes containing which prevents the antibody/antigen interaction [6]. 
various PEG-PEs clearly indicated that the activity of The results of the liposome agglutination assay in- 
PEG-PE in prolonging the circulation time of dicated that PEG750-PE and PEG2000-PE provide 
liposomes directly correlates with the steric barrier ac- much weaker steric barriers than PEG5000-PE (Fig. 1), 
tivity of the amphipathic polymer. These data support although their activities in prolonging the circulation 
the ‘steric barrier hypothesis’ [7] that amphipathic PEG time are also lower than that of PEG5000-PE (Fig. 2). 
prolongs the circulation time of liposomes by presen- We have thus studied the effects of these PEG-PEs on 
ting a steric barrier which reduces the specific and/or the target binding of immunoliposomes. As a model 
nonspecific interaction of liposomes with the RES. system, the monoclonal antibody 34A (34A) system was 
In view of the steric barrier hypothesis, the relation- used in this study. 34A is a rat IgGza antibody which 
ship between the steric barrier activity of GM, and its binds specifically with a glycoprotein antigen, gpI12, 
activity in prolonging the circulation time of liposomes expressed in high concentrations on the lumenal surface 
is ambiguous. Its steric barrier activity is weaker than of the capillary endothelial cells of mouse lung [17,18]. 
that of PEG2000-PE (Fig. l), yet its activity in prolong- The i.v, injected 34A-liposomes gain direct access to the 
ing the circulation time of liposomes is greater than that target and bind efficiently to the lung [19,20]. The lung 
of PEG2000-PE (Fig. 2). In other words, the activity of binding of 34A-liposomes containing PEG-PE or GM, 
GM, in prolonging the circulation time of liposomes was examined I h after i.v. injection and was expressed 
dots not correlate with its steric barrier acticity. More- as 070 injected dose (Table I). The antibody-to-lipid 
over, it has been shown that many higher order ganglio- weight ratio of 34A-liposomes used in this study ranged 
sides such as GDI~ and GTlb have littlc activity in pro- from 1: 13.9 to 1: 18.1. This range of weight ratio did not 
longing the circulation time of liposomes [ 11, although cause a significant change in lung binding as shown in 
these gangliosides contain larger oligosaccharide head- the control 34A-liposomes with the 34A-to-lipid ratio 
groups than GM, and would bc expected to be better of 1:13,9 and 1:1&l (43% and 44%, respectively), In- 
steric barriers for liposomes. It is therefore unlikely that clusion of PEG20OO-PE in the libosomes resulted in 
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Table I 
Effects of various PEG-PEs and GM1 on target binding of immunoliposomes” 
Lipid composition (molar ratio) 34A:lipid 
(w/w) 
Average 
diameter (nm) LuncC 
% injected doseb 
RES Blood 
PC/chol (1: 1) 
PC/chol/GMl (1:1:0.15) 
PC/chol/PEG750PE (1:1:0.15) 
PC/choI/PEG20OOPE (1: 1 :O. 15) 
PC/chol/PEG%OOPE (l:l:O.lS) 
1:18:1 194 43.8 (2.2)” 41.3 (3.5) 9.5 (1.3) 
1:13.9 194 42.9 (3.2)d 41.9 (2.7) 12.5 (0.2) 
1:15.0 188 52.5 (2.9) 35.9 (5.1) 6.3 (0.8) 
1:16.9 192 47.1 (1.8)’ 40.6 (4.6) 7.6 (0.3) 
1:17.7 176 52.6 (2.5)r 34.6 (1.5) 11.4 (1.1) 
1:15.0 163 21.5 (1.2) 21.1 (2.6) 55.0 (2.7) 
’ “‘In-labeled 34A-liposomes with the indicated lipid compositions were i.v. injected (0.4 mg lipid) and % injected dose was measured in 
lung, RES (liver and spleen), and blood 1 h after injection. 
b Data are expressed as mean (SD.), n = 3. 
‘Statistical analysis (Student’s /-test): d vs e, P<C!.Ol; d vs f, PcO.05; d vs g, PcO.01; f vs g, Pc0.02. 
enhanced lung binding (53%) which was the same level 
as found in GMl-containing 34A-liposomes (53%), 
whereas inclusion of PEG750-PE resulted in only a 
slightly enhanced binding (47%). Thus, the presence of 
PEG750-PE or PEG2000-PE on the liposome surface 
does not interfere with the binding of antibody to an- 
tigen and, instead, enhances the target binding of im- 
munoliposomes according to their activities in prolong- 
ing the circulation time of liposomes. On the contrary, 
the steric barrier activity of PEG5000-PE is apparently 
too strong, lessening the antigen/antibody interaction 
of this stystem, resulting in a decreased lung binding 
(22%). Thus, among the PEG-PEs tested, PEC12000- 
PE seems to be the optimal one for target binding of 
immunoliposomes. It should be noted, however, that 
the target antigen for 34A-liposomes is located at a 
readily accessible site, i.e. the vascular endothelial cell 
surface. For a much less accessible target, such as the 
tumor cell surface antigens in a solid tumor, only 
liposomes with a strong steric barrier activity would be 
expected to circulate long enough to reach the target. It 
is thus of interest to test the PEGS of higher molecular 
weights in targeting system where the antigen is in less 
accessible sites. 
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